{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:14:21Z","timestamp":1778166861922,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NSYSU-KMU joint research project","award":["NSYSUKMU112-P03"],"award-info":[{"award-number":["NSYSUKMU112-P03"]}]},{"name":"NSYSU-KMU joint research project","award":["NSYSUKMU112-P03"],"award-info":[{"award-number":["NSYSUKMU112-P03"]}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2628-H-037-001"],"award-info":[{"award-number":["NSTC112-2628-H-037-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Educ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Taiwan\u2019s unique health behaviour, such as extensive exposure to Chinese Herbal Medicine (CHM), has introduced a risk of inadvertent doping among competing athletes. Pharmacy professionals have an imperative role in advising athletes on the safe use of medicines. This study provides an overview of anti-doping knowledge and educational needs among pharmacists in Taiwan and examines influencing factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional online questionnaire survey consisting of five domains, namely demographic characteristics, source of prohibited substances, identification of prohibited substances, understanding of doping control, and education needs on anti-doping, was distributed to the registered pharmacists in Taiwan. In total, 491 responses were included in the analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Respondents (65% female, aged 41.9\u2009\u00b1\u200911.4\u00a0years, with 68% having a Bachelor\u2019s degree) reported a moderate anti-doping knowledge score of 37.2\u2009\u00b1\u20094.9, ranging from 21 to 48 (out of 51). Fifteen per cent of them had the experience of being counselled about drug use in sports. Higher knowledge scores were observed in younger respondents, showing an age-dependent effect (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Individuals practising in southern Taiwan (compared to northern Taiwan) and those working at clinics (compared to hospitals) exhibited lower knowledge. Most of the respondents (90%) knew that stimulant ephedrine is prohibited in sports, but few had recognised diuretic furosemide (38%) and CHM (7%) containing \u03b2<jats:sub>2<\/jats:sub>-agonist higenamine. Approximately 90% of respondents agreed with the need for anti-doping education.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study highlights the heterogeneity of anti-doping knowledge among pharmacy professionals and provides practical relevance in organising future educational topics and research-based activities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12909-023-04795-z","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:03:22Z","timestamp":1698404602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessing anti-doping knowledge among Taiwanese pharmacists"],"prefix":"10.1186","volume":"23","author":[{"given":"Yun-Chen","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Yun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Chich","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Chih-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"4795_CR1","unstructured":"World Anti-Doping Agency. The 2023 List of Prohibited Substances and Methods 2022 [Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/2022-09\/2023list_en_final_9_september_2022.pdf."},{"key":"4795_CR2","unstructured":"World Anti-Doping Agency. Athlete Biological Passport Operating Guidelines 2021 [Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/guidelines_abp_v8_final.pdf."},{"key":"4795_CR3","unstructured":"Badminton World Federation. Decision 2019\/03 of the Badminton World Federation Doping Hearing Panel Decision 2019 [Available from: https:\/\/extranet.bwf.sport\/docs\/document-system\/81\/210\/382\/BWF%20v%20%20Ms%20Ratchanok%20Intanon%20_%20BWF%20ID%2035642%20_%20Reasoned%20Deision.pdf."},{"key":"4795_CR4","unstructured":"Court of Arbitration for Sport. CAS OG 22\/08 -CAS OG 22\/09 -CAS OG 22\/10 International Olympic Committee World Anti-Doping Agency International Skating Union v. Russian Anti-Doping Agency Kamila Valieva Russian Olympic Committee 2022 [Available from: https:\/\/www.tas-cas.org\/fileadmin\/user_upload\/OG_22_08-09-10_Arbitral_Award__publication_.pdf."},{"key":"4795_CR5","unstructured":"World Anti-Doping Agency. World Anti-Doping Code 2021 [Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2021_wada_code.pdf."},{"key":"4795_CR6","unstructured":"International Pharmaceutical Federation. FIP Guidelines: the role of the pharmacist in the fight against doping in sport 2014 [Available from: https:\/\/www.fip.org\/file\/1513."},{"issue":"6","key":"4795_CR7","first-page":"817","volume":"56","author":"D Mottram","year":"2015","unstructured":"Mottram D, Khalifa S, Alemrayat B, Rahhal A, Ahmed A, Stuart M, et al. Perspective of pharmacists in Qatar regarding doping and anti-doping in sports. J Sports Med Phys Fitness. 2015;56(6):817\u201324.","journal-title":"J Sports Med Phys Fitness"},{"issue":"4","key":"4795_CR8","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.japh.2018.05.003","volume":"58","author":"MS Howard","year":"2018","unstructured":"Howard MS, DiDonato KL, Janovick DL, Schroeder MN, Powers MF, Azzi AG, et al. Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: An exploratory study. J Am Pharm Assoc. 2018;58(4):S30-S6 e2.","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"4795_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/pharmacy8010010","volume":"8","author":"KC Yee","year":"2020","unstructured":"Yee KC, De Marco M, Salahudeen MS, Peterson GM, Thomas J, Naunton M, et al. Pharmacists as a source of advice on medication use for athletes. Pharmacy. 2020;8(1):10.","journal-title":"Pharmacy"},{"key":"4795_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/IPRP.S311204","volume":"10","author":"H Gebregergs Hailu","year":"2021","unstructured":"Gebregergs Hailu H, Yirsaw Gobezie M, Tuha A, Mulugeta R, Ahmed MS. Doping knowledge, attitude and practice of pharmacists in dessie, Northeast Ethiopia. Integrated Pharmacy Research & Practice. 2021;10:43\u201350.","journal-title":"Integrated Pharmacy Research & Practice"},{"issue":"2","key":"4795_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.peh.2021.100195","volume":"9","author":"M Lemettil\u00e4","year":"2021","unstructured":"Lemettil\u00e4 M, Lepp\u00e4 E, Pohjanoksa-M\u00e4ntyl\u00e4 M, Simula A, Koskelo J. Anti-doping knowledge and educational needs of Finnish pharmacists. Performance Enhancement Health. 2021;9(2): 100195.","journal-title":"Performance Enhancement Health"},{"issue":"6","key":"4795_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268878","volume":"17","author":"N Voravuth","year":"2022","unstructured":"Voravuth N, Chua EW, Tuan Mahmood TM, Lim MC, Wan Puteh SE, Safii NS, et al. Engaging community pharmacists to eliminate inadvertent doping in sports: a study of their knowledge on doping. PLoS ONE. 2022;17(6): e0268878.","journal-title":"PLoS ONE"},{"issue":"3","key":"4795_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/ijpp\/riad015","volume":"31","author":"DH Greenbaum","year":"2023","unstructured":"Greenbaum DH, McLachlan AJ, Roubin RH, Moles R, Chaar BB. Examining pharmacists\u2019 anti-doping knowledge and skills in assisting athletes to avoid unintentional use of prohibited substances. Int J Pharm Pract. 2023;31(3):290\u20137.","journal-title":"Int J Pharm Pract"},{"key":"4795_CR14","unstructured":"Numbeo. Health Care Index by Country 2023 2023 [Available from: https:\/\/www.numbeo.com\/health-care\/rankings_by_country.jsp."},{"key":"4795_CR15","unstructured":"Ministry of Health and Welfare. [Available from: https:\/\/www.mohw.gov.tw\/lp-86-1.html."},{"issue":"12","key":"4795_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208569","volume":"13","author":"CW Huang","year":"2018","unstructured":"Huang CW, Hwang IH, Lee YS, Hwang SJ, Ko SG, Chen FP, et al. Utilization patterns of traditional medicine in Taiwan and South Korea by using national health insurance data in 2011. PLoS ONE. 2018;13(12): e0208569.","journal-title":"PLoS ONE"},{"key":"4795_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1472-6963-7-26","volume":"7","author":"FP Chen","year":"2007","unstructured":"Chen FP, Chen TJ, Kung YY, Chen YC, Chou LF, Chen FJ, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res. 2007;7:26.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"4795_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/dta.2209","volume":"10","author":"CW Chang","year":"2018","unstructured":"Chang CW, Hsu SY, Huang GQ, Hsu MC. Ephedra alkaloid contents of Chinese herbal formulae sold in Taiwan. Drug Test Anal. 2018;10(2):350\u20136.","journal-title":"Drug Test Anal"},{"issue":"2","key":"4795_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/bjsports-2012-090988","volume":"47","author":"M Thevis","year":"2013","unstructured":"Thevis M, Sch\u00e4nzer W, Geyer H, Thieme D, Grosse J, Rautenberg C, et al. Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts. Br J Sports Med. 2013;47(2):109\u201314.","journal-title":"Br J Sports Med"},{"issue":"2","key":"4795_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/nu12020285","volume":"12","author":"C-C Yen","year":"2020","unstructured":"Yen C-C, Tung C-W, Chang C-W, Tsai C-C, Hsu M-C, Wu Y-T. Potential risk of higenamine misuse in sports: Evaluation of lotus plumule extract products and a human study. Nutrients. 2020;12(2):285.","journal-title":"Nutrients"},{"issue":"3","key":"4795_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.13048\/jkm.19032","volume":"40","author":"J-R Kim","year":"2019","unstructured":"Kim J-R, Yun SJ, Lee YK, Lee H-J, Kim JS. A review on safety of herbal medicines for doping. J Korean Med. 2019;40(3):139\u201376.","journal-title":"J Korean Med"},{"issue":"1","key":"4795_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/pharmacy7010029","volume":"7","author":"AD Hooper","year":"2019","unstructured":"Hooper AD, Cooper JM, Schneider J, Kairuz T. Current and potential roles in sports pharmacy: a systematic review. Pharmacy. 2019;7(1):29.","journal-title":"Pharmacy"},{"key":"4795_CR23","unstructured":"Ming-Han Chen I-CC, Ying-Chou Lin, Lih-Chi Chen. Implementation of anti-doping alert system. J Taiwan Pharmacy. 2019;35(4)."},{"issue":"6","key":"4795_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/0142159X.2014.889814","volume":"36","author":"AR Artino Jr","year":"2014","unstructured":"Artino AR Jr, La Rochelle JS, Dezee KJ, Gehlbach H. Developing questionnaires for educational research: AMEE Guide No. 87. Med Teach. 2014;36(6):463\u201374.","journal-title":"Med Teach"},{"issue":"2","key":"4795_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.15171\/jcs.2015.017","volume":"4","author":"V Zamanzadeh","year":"2015","unstructured":"Zamanzadeh V, Ghahramanian A, Rassouli M, Abbaszadeh A, Alavi-Majd H, Nikanfar A-R. Design and implementation content validity study: development of an instrument for measuring patient-centered communication. J Caring Sci. 2015;4(2):165.","journal-title":"J Caring Sci"},{"key":"4795_CR26","unstructured":"World Health Organization. Global Health Workforce Statistics 2018 [Available from: http:\/\/www.who.int\/hrh\/statistics\/hwfstats\/."},{"key":"4795_CR27","unstructured":"World Anti-Doping Agency. Anti-Doping Testing Figures Report 2021 [Available from: https:\/\/www.wada-ama.org\/en\/resources\/anti-doping-stats\/anti-doping-testing-figures-report#resource-download."},{"key":"4795_CR28","unstructured":"International Pharmaceutical Federation. Sports pharmacy practice and education: A global overview 2022 [Available from: https:\/\/www.fip.org\/file\/5391."},{"issue":"1","key":"4795_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12909-019-1602-2","volume":"19","author":"CJ Wei","year":"2019","unstructured":"Wei CJ, Lu TH, Chien SC, Huang WT, Liu YP, Chan CY, et al. The development and use of a pharmacist-specific Mini-CEX for postgraduate year trainees in Taiwan. BMC Med Educ. 2019;19(1):165.","journal-title":"BMC Med Educ"},{"key":"4795_CR30","unstructured":"Sports Administration. \u904b\u52d5\u7981\u85e5\u6559\u80b2\u9032\u6821\u5712 \u6253\u9020\u5065\u5eb7\u904b\u52d5\u65b0\u89c0\u5ff5 Ministry of Education2022 [Available from: https:\/\/www.edu.tw\/News_Content.aspx?n=9E7AC85F1954DDA8&s=AB8776265B445286#."},{"issue":"1","key":"4795_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13104-017-2713-7","volume":"10","author":"K Shibata","year":"2017","unstructured":"Shibata K, Ichikawa K, Kurata N. Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey. BMC Res Notes. 2017;10(1):396.","journal-title":"BMC Res Notes"}],"container-title":["BMC Medical Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-023-04795-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12909-023-04795-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-023-04795-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:05:30Z","timestamp":1698404730000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmededuc.biomedcentral.com\/articles\/10.1186\/s12909-023-04795-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4795"],"URL":"https:\/\/doi.org\/10.1186\/s12909-023-04795-z","relation":{},"ISSN":["1472-6920"],"issn-type":[{"value":"1472-6920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"26 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the principles of the Declaration of Helsinki. The study was approved by the Institutional Review Board (IRB), Kaohsiung Medical University Chung-Ho Memorial Hospital (reference: KMUHIRB-E(I)-20220158). The IRB has approved the waiver of informed consent as this study is an anonymous online survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"808"}}